Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

152.64 -0.49 (-0.32%)
Streaming Delayed Price Updated: 10:20 AM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 729,491
Open 153.64
Bid (Size) 152.62 (2)
Ask (Size) 152.70 (1)
Prev. Close 153.13
Today's Range 151.44 - 153.83
52wk Range 130.96 - 168.11
Shares Outstanding N/A
Dividend Yield 3.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Via Benzinga
Three Of Our Top Picks For Your Healthcare Portfolio
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets

Performance

YTD
-6.00%
-6.00%
1 Month
+3.53%
+3.53%
3 Month
+15.19%
+15.19%
6 Month
-3.39%
-3.39%
1 Year
+7.71%
+7.71%

More News

Read More
AbbVie Unusual Options Activity
Via Benzinga
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
Via InvestorPlace
Clorox Pullback Presents a Chance to Clean Up on a 3.6% Dividend
Via MarketBeat
How Is The Market Feeling About AbbVie?
Via Benzinga
This Is What Whales Are Betting On AbbVie
Via Benzinga
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
Via Benzinga
AbbVie Unusual Options Activity For September 13
Via Benzinga
Argenx's 28% Surge & Promising Product Propel Investor Confidence
Via MarketBeat
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Only 7 Large-Cap Dividend Kings Yield Over 3%. Here's My Top Pick to Buy Now.
Via The Motley Fool
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
2 Undervalued Dividend Stocks to Buy Now
Via The Motley Fool
Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke
Via Investor's Business Daily
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Via InvestorPlace
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
Via FinancialNewsMedia
Topics Economy
Exposures Economy Product Safety
The Top 7 Underrated Dividend Stocks Yielding 3% or More
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Dividend Kings to Buy on the Dip and Hold Forever
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Is Immuno-Oncology Firm Harpoon Therapeutics Stock Trading Lower Today?
Via Benzinga
High Yield, Low Beta Stocks to Buy for the Next Market Meltdown
Via MarketBeat
Topics Economy Stocks
Exposures Economy Interest Rates US Equities
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.